Pr. Charles DUMONTET - Scientific Advisory Board member and Co-founder of Mablink Bioscience
Pr. Charles Dumontet is Professor of Hematology at the University of Lyon, Deputy Director of the Centre de Recherche en Cancérologie de Lyon (CRCL), Director of the Antibodies Anticancer lab (UMR CNRS INSERM 1052) and Medical Doctor in Hematology at the Lyon South Hospital. He is the author of more than 300 peer-reviewed scientific publications and several patents. Pr. Dumontet is a world reference in the therapeutic antibody and antibody-drug conjugate (ADC) fields of research. He has a critical and constructive outlook on clinical applications and development of ADCs and is involved in numerous international events in the field. He recently co-authored a review article on ADCs (« Strategies and challenges for the next generation of antibody-drug conjugates », Nat. Rev. Drug. Deliv. Review, 16(5), 315-337, 2017). Pr. Dumontet’s lab regularly collaborates with major European players in the immuno-oncology field (Roche, Sanofi, Servier, Pierre Fabre…).
Pr. Benoît JOSEPH - Scientific Advisory Board member and Co-founder of Mablink Bioscience
Pr. Benoît Joseph is Professor of organic chemistry and director of the SMITh lab at the Chemistry and Biochemistry Institute (ICBMS – UMR CNRS 5246) of the University of Lyon. With more than 25 years of experience in chemical synthesis of cytotoxic compounds and more broadly in medicinal chemistry, Pr. Benoît Joseph is a key contributor regarding drug-linker chemical synthesis and the identification of new cytotoxic entities. He is the author of more than 90 peer-reviewed scientific publications and several patents.